nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—ALB—ulcerative colitis	0.212	0.512	CbGaD
Mirabegron—ABCB1—ulcerative colitis	0.202	0.488	CbGaD
Mirabegron—BCHE—Triamcinolone—ulcerative colitis	0.0613	0.126	CbGbCtD
Mirabegron—SLCO1A2—Prednisolone—ulcerative colitis	0.0487	0.1	CbGbCtD
Mirabegron—SLCO1A2—Hydrocortisone—ulcerative colitis	0.0462	0.0953	CbGbCtD
Mirabegron—SLCO1A2—Prednisone—ulcerative colitis	0.046	0.0949	CbGbCtD
Mirabegron—SLCO1A2—Dexamethasone—ulcerative colitis	0.0287	0.0592	CbGbCtD
Mirabegron—CYP3A4—Budesonide—ulcerative colitis	0.0275	0.0568	CbGbCtD
Mirabegron—ALB—Prednisone—ulcerative colitis	0.0238	0.049	CbGbCtD
Mirabegron—ABCB1—Methylprednisolone—ulcerative colitis	0.0205	0.0423	CbGbCtD
Mirabegron—CYP2D6—Nicotine—ulcerative colitis	0.0188	0.0389	CbGbCtD
Mirabegron—CYP2D6—Cholecalciferol—ulcerative colitis	0.0169	0.0349	CbGbCtD
Mirabegron—ABCB1—Betamethasone—ulcerative colitis	0.0133	0.0275	CbGbCtD
Mirabegron—ABCB1—Prednisolone—ulcerative colitis	0.0132	0.0272	CbGbCtD
Mirabegron—ABCB1—Hydrocortisone—ulcerative colitis	0.0125	0.0257	CbGbCtD
Mirabegron—ABCB1—Prednisone—ulcerative colitis	0.0124	0.0256	CbGbCtD
Mirabegron—CYP3A4—Methylprednisolone—ulcerative colitis	0.0123	0.0254	CbGbCtD
Mirabegron—CYP3A4—Nicotine—ulcerative colitis	0.012	0.0247	CbGbCtD
Mirabegron—CYP3A4—Cholecalciferol—ulcerative colitis	0.0108	0.0222	CbGbCtD
Mirabegron—CYP3A4—Triamcinolone—ulcerative colitis	0.00932	0.0192	CbGbCtD
Mirabegron—CYP3A4—Betamethasone—ulcerative colitis	0.008	0.0165	CbGbCtD
Mirabegron—CYP3A4—Prednisolone—ulcerative colitis	0.00789	0.0163	CbGbCtD
Mirabegron—ABCB1—Dexamethasone—ulcerative colitis	0.00776	0.016	CbGbCtD
Mirabegron—CYP3A4—Hydrocortisone—ulcerative colitis	0.00748	0.0154	CbGbCtD
Mirabegron—CYP3A4—Prednisone—ulcerative colitis	0.00745	0.0154	CbGbCtD
Mirabegron—CYP2D6—Dexamethasone—ulcerative colitis	0.00732	0.0151	CbGbCtD
Mirabegron—CYP3A4—Dexamethasone—ulcerative colitis	0.00465	0.00959	CbGbCtD
Mirabegron—Arbutamine—ADRB2—ulcerative colitis	0.00135	0.511	CrCbGaD
Mirabegron—Labetalol—ADRB2—ulcerative colitis	0.000955	0.363	CrCbGaD
Mirabegron—Osteoarthritis—Prednisolone—ulcerative colitis	0.000344	0.00363	CcSEcCtD
Mirabegron—Sinusitis—Mesalazine—ulcerative colitis	0.000342	0.0036	CcSEcCtD
Mirabegron—Erythema multiforme—Azathioprine—ulcerative colitis	0.000339	0.00358	CcSEcCtD
Mirabegron—Gastrointestinal pain—Nicotine—ulcerative colitis	0.000339	0.00358	CcSEcCtD
Mirabegron—Back pain—Budesonide—ulcerative colitis	0.000339	0.00357	CcSEcCtD
Mirabegron—Osteoarthritis—Hydrocortisone—ulcerative colitis	0.000336	0.00355	CcSEcCtD
Mirabegron—Propafenone—ABCB1—ulcerative colitis	0.000333	0.126	CrCbGaD
Mirabegron—Vision blurred—Budesonide—ulcerative colitis	0.00033	0.00348	CcSEcCtD
Mirabegron—Urticaria—Nicotine—ulcerative colitis	0.000329	0.00348	CcSEcCtD
Mirabegron—Purpura—Triamcinolone—ulcerative colitis	0.000328	0.00346	CcSEcCtD
Mirabegron—Abdominal pain—Nicotine—ulcerative colitis	0.000328	0.00346	CcSEcCtD
Mirabegron—Rhinitis—Mesalazine—ulcerative colitis	0.000328	0.00346	CcSEcCtD
Mirabegron—Urinary tract disorder—Mesalazine—ulcerative colitis	0.000323	0.00341	CcSEcCtD
Mirabegron—Connective tissue disorder—Mesalazine—ulcerative colitis	0.000321	0.00339	CcSEcCtD
Mirabegron—Urethral disorder—Mesalazine—ulcerative colitis	0.00032	0.00338	CcSEcCtD
Mirabegron—Osteoarthritis—Triamcinolone—ulcerative colitis	0.000316	0.00334	CcSEcCtD
Mirabegron—Osteoarthritis—Methylprednisolone—ulcerative colitis	0.000316	0.00333	CcSEcCtD
Mirabegron—Palpitations—Budesonide—ulcerative colitis	0.000309	0.00326	CcSEcCtD
Mirabegron—Erythema multiforme—Mesalazine—ulcerative colitis	0.000309	0.00326	CcSEcCtD
Mirabegron—Eye disorder—Mesalazine—ulcerative colitis	0.000306	0.00322	CcSEcCtD
Mirabegron—Cardiac disorder—Mesalazine—ulcerative colitis	0.000303	0.0032	CcSEcCtD
Mirabegron—Hypertension—Budesonide—ulcerative colitis	0.000302	0.00319	CcSEcCtD
Mirabegron—Abdominal distension—Prednisolone—ulcerative colitis	0.000299	0.00316	CcSEcCtD
Mirabegron—Arthralgia—Budesonide—ulcerative colitis	0.000298	0.00314	CcSEcCtD
Mirabegron—Asthenia—Nicotine—ulcerative colitis	0.000298	0.00314	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Hydrocortisone—ulcerative colitis	0.000296	0.00313	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.000296	0.00312	CcSEcCtD
Mirabegron—Pruritus—Nicotine—ulcerative colitis	0.000293	0.0031	CcSEcCtD
Mirabegron—Diarrhoea—Mercaptopurine—ulcerative colitis	0.000293	0.00309	CcSEcCtD
Mirabegron—Abdominal distension—Hydrocortisone—ulcerative colitis	0.000292	0.00308	CcSEcCtD
Mirabegron—Dry mouth—Budesonide—ulcerative colitis	0.000291	0.00307	CcSEcCtD
Mirabegron—Osteoarthritis—Dexamethasone—ulcerative colitis	0.000287	0.00303	CcSEcCtD
Mirabegron—Osteoarthritis—Betamethasone—ulcerative colitis	0.000287	0.00303	CcSEcCtD
Mirabegron—Breast disorder—Methylprednisolone—ulcerative colitis	0.000285	0.00301	CcSEcCtD
Mirabegron—Diarrhoea—Nicotine—ulcerative colitis	0.000284	0.00299	CcSEcCtD
Mirabegron—Infection—Budesonide—ulcerative colitis	0.000284	0.00299	CcSEcCtD
Mirabegron—Vascular purpura—Prednisone—ulcerative colitis	0.00028	0.00295	CcSEcCtD
Mirabegron—Tachycardia—Budesonide—ulcerative colitis	0.000279	0.00294	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Methylprednisolone—ulcerative colitis	0.000278	0.00294	CcSEcCtD
Mirabegron—Skin disorder—Budesonide—ulcerative colitis	0.000277	0.00293	CcSEcCtD
Mirabegron—Abdominal distension—Triamcinolone—ulcerative colitis	0.000275	0.0029	CcSEcCtD
Mirabegron—Back pain—Mesalazine—ulcerative colitis	0.000275	0.0029	CcSEcCtD
Mirabegron—Abdominal distension—Methylprednisolone—ulcerative colitis	0.000275	0.0029	CcSEcCtD
Mirabegron—Dizziness—Nicotine—ulcerative colitis	0.000274	0.00289	CcSEcCtD
Mirabegron—Influenza—Triamcinolone—ulcerative colitis	0.000273	0.00289	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Hydrocortisone—ulcerative colitis	0.00027	0.00285	CcSEcCtD
Mirabegron—Rash—Mercaptopurine—ulcerative colitis	0.00027	0.00285	CcSEcCtD
Mirabegron—Dermatitis—Mercaptopurine—ulcerative colitis	0.00027	0.00284	CcSEcCtD
Mirabegron—ORM1—bile—ulcerative colitis	0.000269	0.551	CbGeAlD
Mirabegron—Vision blurred—Mesalazine—ulcerative colitis	0.000268	0.00283	CcSEcCtD
Mirabegron—Arthralgia—Azathioprine—ulcerative colitis	0.000266	0.00281	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000264	0.00279	CcSEcCtD
Mirabegron—Rash—Nicotine—ulcerative colitis	0.000261	0.00276	CcSEcCtD
Mirabegron—Dermatitis—Nicotine—ulcerative colitis	0.000261	0.00276	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Budesonide—ulcerative colitis	0.00026	0.00275	CcSEcCtD
Mirabegron—Headache—Nicotine—ulcerative colitis	0.00026	0.00274	CcSEcCtD
Mirabegron—Purpura—Prednisone—ulcerative colitis	0.000259	0.00274	CcSEcCtD
Mirabegron—Infestation—Hydrocortisone—ulcerative colitis	0.000259	0.00273	CcSEcCtD
Mirabegron—Infestation NOS—Hydrocortisone—ulcerative colitis	0.000259	0.00273	CcSEcCtD
Mirabegron—Nausea—Mercaptopurine—ulcerative colitis	0.000254	0.00268	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Triamcinolone—ulcerative colitis	0.000254	0.00268	CcSEcCtD
Mirabegron—Infection—Azathioprine—ulcerative colitis	0.000253	0.00267	CcSEcCtD
Mirabegron—Palpitations—Mesalazine—ulcerative colitis	0.000252	0.00265	CcSEcCtD
Mirabegron—Dyspepsia—Budesonide—ulcerative colitis	0.000251	0.00265	CcSEcCtD
Mirabegron—Osteoarthritis—Prednisone—ulcerative colitis	0.00025	0.00264	CcSEcCtD
Mirabegron—Skin disorder—Azathioprine—ulcerative colitis	0.000248	0.00261	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000247	0.0026	CcSEcCtD
Mirabegron—Nausea—Nicotine—ulcerative colitis	0.000246	0.0026	CcSEcCtD
Mirabegron—Fatigue—Budesonide—ulcerative colitis	0.000246	0.0026	CcSEcCtD
Mirabegron—Hypertension—Mesalazine—ulcerative colitis	0.000246	0.00259	CcSEcCtD
Mirabegron—Constipation—Budesonide—ulcerative colitis	0.000244	0.00258	CcSEcCtD
Mirabegron—Infestation—Methylprednisolone—ulcerative colitis	0.000243	0.00257	CcSEcCtD
Mirabegron—Infestation NOS—Methylprednisolone—ulcerative colitis	0.000243	0.00257	CcSEcCtD
Mirabegron—Arthralgia—Mesalazine—ulcerative colitis	0.000242	0.00256	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000241	0.00254	CcSEcCtD
Mirabegron—Dry mouth—Mesalazine—ulcerative colitis	0.000237	0.0025	CcSEcCtD
Mirabegron—Gastrointestinal pain—Budesonide—ulcerative colitis	0.000234	0.00246	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Azathioprine—ulcerative colitis	0.000232	0.00245	CcSEcCtD
Mirabegron—Infection—Mesalazine—ulcerative colitis	0.000231	0.00243	CcSEcCtD
Mirabegron—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.000228	0.00241	CcSEcCtD
Mirabegron—Urticaria—Budesonide—ulcerative colitis	0.000227	0.00239	CcSEcCtD
Mirabegron—Tachycardia—Mesalazine—ulcerative colitis	0.000227	0.00239	CcSEcCtD
Mirabegron—Abdominal pain—Budesonide—ulcerative colitis	0.000226	0.00238	CcSEcCtD
Mirabegron—Skin disorder—Mesalazine—ulcerative colitis	0.000226	0.00238	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Prednisone—ulcerative colitis	0.000221	0.00233	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.00022	0.00232	CcSEcCtD
Mirabegron—Rhinitis—Triamcinolone—ulcerative colitis	0.000219	0.00232	CcSEcCtD
Mirabegron—Rhinitis—Methylprednisolone—ulcerative colitis	0.000219	0.00231	CcSEcCtD
Mirabegron—Abdominal distension—Prednisone—ulcerative colitis	0.000218	0.0023	CcSEcCtD
Mirabegron—Eye disorder—Hydrocortisone—ulcerative colitis	0.000217	0.00229	CcSEcCtD
Mirabegron—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000215	0.00226	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000212	0.00223	CcSEcCtD
Mirabegron—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000209	0.0022	CcSEcCtD
Mirabegron—Asthenia—Budesonide—ulcerative colitis	0.000205	0.00216	CcSEcCtD
Mirabegron—Dyspepsia—Mesalazine—ulcerative colitis	0.000204	0.00216	CcSEcCtD
Mirabegron—Eye disorder—Methylprednisolone—ulcerative colitis	0.000204	0.00215	CcSEcCtD
Mirabegron—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000203	0.00214	CcSEcCtD
Mirabegron—Pruritus—Budesonide—ulcerative colitis	0.000202	0.00213	CcSEcCtD
Mirabegron—Abdominal pain—Azathioprine—ulcerative colitis	0.000202	0.00213	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000201	0.00212	CcSEcCtD
Mirabegron—Fatigue—Mesalazine—ulcerative colitis	0.0002	0.00211	CcSEcCtD
Mirabegron—Constipation—Mesalazine—ulcerative colitis	0.000199	0.0021	CcSEcCtD
Mirabegron—Diarrhoea—Budesonide—ulcerative colitis	0.000195	0.00206	CcSEcCtD
Mirabegron—Vision blurred—Prednisolone—ulcerative colitis	0.000195	0.00206	CcSEcCtD
Mirabegron—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.00019	0.002	CcSEcCtD
Mirabegron—Dizziness—Budesonide—ulcerative colitis	0.000189	0.00199	CcSEcCtD
Mirabegron—Eye disorder—Dexamethasone—ulcerative colitis	0.000186	0.00196	CcSEcCtD
Mirabegron—Eye disorder—Betamethasone—ulcerative colitis	0.000186	0.00196	CcSEcCtD
Mirabegron—Urticaria—Mesalazine—ulcerative colitis	0.000185	0.00195	CcSEcCtD
Mirabegron—Back pain—Triamcinolone—ulcerative colitis	0.000184	0.00194	CcSEcCtD
Mirabegron—Abdominal pain—Mesalazine—ulcerative colitis	0.000184	0.00194	CcSEcCtD
Mirabegron—Rash—Budesonide—ulcerative colitis	0.00018	0.0019	CcSEcCtD
Mirabegron—Dermatitis—Budesonide—ulcerative colitis	0.00018	0.0019	CcSEcCtD
Mirabegron—Headache—Budesonide—ulcerative colitis	0.000179	0.00189	CcSEcCtD
Mirabegron—Hypertension—Prednisolone—ulcerative colitis	0.000179	0.00189	CcSEcCtD
Mirabegron—Hypertension—Hydrocortisone—ulcerative colitis	0.000175	0.00184	CcSEcCtD
Mirabegron—Diarrhoea—Azathioprine—ulcerative colitis	0.000174	0.00184	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000171	0.00181	CcSEcCtD
Mirabegron—Connective tissue disorder—Prednisone—ulcerative colitis	0.00017	0.00179	CcSEcCtD
Mirabegron—Nausea—Budesonide—ulcerative colitis	0.00017	0.00179	CcSEcCtD
Mirabegron—Dizziness—Azathioprine—ulcerative colitis	0.000169	0.00178	CcSEcCtD
Mirabegron—Asthenia—Mesalazine—ulcerative colitis	0.000167	0.00176	CcSEcCtD
Mirabegron—Tachycardia—Prednisolone—ulcerative colitis	0.000165	0.00174	CcSEcCtD
Mirabegron—Hypertension—Triamcinolone—ulcerative colitis	0.000165	0.00174	CcSEcCtD
Mirabegron—Pruritus—Mesalazine—ulcerative colitis	0.000164	0.00173	CcSEcCtD
Mirabegron—Hypertension—Methylprednisolone—ulcerative colitis	0.000164	0.00173	CcSEcCtD
Mirabegron—Infection—Hydrocortisone—ulcerative colitis	0.000164	0.00173	CcSEcCtD
Mirabegron—Arthralgia—Methylprednisolone—ulcerative colitis	0.000162	0.00171	CcSEcCtD
Mirabegron—Eye disorder—Prednisone—ulcerative colitis	0.000162	0.00171	CcSEcCtD
Mirabegron—Tachycardia—Hydrocortisone—ulcerative colitis	0.000161	0.0017	CcSEcCtD
Mirabegron—Rash—Azathioprine—ulcerative colitis	0.000161	0.0017	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000161	0.0017	CcSEcCtD
Mirabegron—Dermatitis—Azathioprine—ulcerative colitis	0.000161	0.00169	CcSEcCtD
Mirabegron—Skin disorder—Hydrocortisone—ulcerative colitis	0.00016	0.00169	CcSEcCtD
Mirabegron—Headache—Azathioprine—ulcerative colitis	0.00016	0.00169	CcSEcCtD
Mirabegron—Diarrhoea—Mesalazine—ulcerative colitis	0.000159	0.00168	CcSEcCtD
Mirabegron—Dry mouth—Triamcinolone—ulcerative colitis	0.000159	0.00167	CcSEcCtD
Mirabegron—Infection—Triamcinolone—ulcerative colitis	0.000155	0.00163	CcSEcCtD
Mirabegron—Infection—Methylprednisolone—ulcerative colitis	0.000154	0.00163	CcSEcCtD
Mirabegron—Dizziness—Mesalazine—ulcerative colitis	0.000154	0.00162	CcSEcCtD
Mirabegron—Tachycardia—Triamcinolone—ulcerative colitis	0.000152	0.0016	CcSEcCtD
Mirabegron—Nausea—Azathioprine—ulcerative colitis	0.000151	0.0016	CcSEcCtD
Mirabegron—Tachycardia—Methylprednisolone—ulcerative colitis	0.000151	0.0016	CcSEcCtD
Mirabegron—Skin disorder—Methylprednisolone—ulcerative colitis	0.000151	0.00159	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.00015	0.00159	CcSEcCtD
Mirabegron—Hypertension—Betamethasone—ulcerative colitis	0.000149	0.00157	CcSEcCtD
Mirabegron—Hypertension—Dexamethasone—ulcerative colitis	0.000149	0.00157	CcSEcCtD
Mirabegron—Rash—Mesalazine—ulcerative colitis	0.000146	0.00155	CcSEcCtD
Mirabegron—Dermatitis—Mesalazine—ulcerative colitis	0.000146	0.00154	CcSEcCtD
Mirabegron—Headache—Mesalazine—ulcerative colitis	0.000146	0.00154	CcSEcCtD
Mirabegron—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000145	0.00153	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000143	0.0015	CcSEcCtD
Mirabegron—Fatigue—Hydrocortisone—ulcerative colitis	0.000142	0.0015	CcSEcCtD
Mirabegron—Vision blurred—Prednisone—ulcerative colitis	0.000142	0.0015	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000142	0.00149	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000141	0.00149	CcSEcCtD
Mirabegron—Infection—Betamethasone—ulcerative colitis	0.00014	0.00148	CcSEcCtD
Mirabegron—Infection—Dexamethasone—ulcerative colitis	0.00014	0.00148	CcSEcCtD
Mirabegron—Nausea—Mesalazine—ulcerative colitis	0.000138	0.00146	CcSEcCtD
Mirabegron—Tachycardia—Betamethasone—ulcerative colitis	0.000138	0.00145	CcSEcCtD
Mirabegron—Tachycardia—Dexamethasone—ulcerative colitis	0.000138	0.00145	CcSEcCtD
Mirabegron—Dyspepsia—Triamcinolone—ulcerative colitis	0.000137	0.00144	CcSEcCtD
Mirabegron—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000137	0.00144	CcSEcCtD
Mirabegron—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000135	0.00142	CcSEcCtD
Mirabegron—Urticaria—Prednisolone—ulcerative colitis	0.000134	0.00142	CcSEcCtD
Mirabegron—Fatigue—Triamcinolone—ulcerative colitis	0.000134	0.00141	CcSEcCtD
Mirabegron—Fatigue—Methylprednisolone—ulcerative colitis	0.000134	0.00141	CcSEcCtD
Mirabegron—Urticaria—Hydrocortisone—ulcerative colitis	0.000131	0.00138	CcSEcCtD
Mirabegron—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000131	0.00138	CcSEcCtD
Mirabegron—Hypertension—Prednisone—ulcerative colitis	0.00013	0.00137	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000129	0.00136	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000129	0.00136	CcSEcCtD
Mirabegron—Arthralgia—Prednisone—ulcerative colitis	0.000128	0.00135	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000127	0.00134	CcSEcCtD
Mirabegron—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000127	0.00134	CcSEcCtD
Mirabegron—Dyspepsia—Betamethasone—ulcerative colitis	0.000124	0.00131	CcSEcCtD
Mirabegron—Dyspepsia—Dexamethasone—ulcerative colitis	0.000124	0.00131	CcSEcCtD
Mirabegron—Urticaria—Triamcinolone—ulcerative colitis	0.000124	0.0013	CcSEcCtD
Mirabegron—Urticaria—Methylprednisolone—ulcerative colitis	0.000123	0.0013	CcSEcCtD
Mirabegron—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000123	0.00129	CcSEcCtD
Mirabegron—Infection—Prednisone—ulcerative colitis	0.000122	0.00129	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000122	0.00129	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000122	0.00129	CcSEcCtD
Mirabegron—Fatigue—Dexamethasone—ulcerative colitis	0.000122	0.00128	CcSEcCtD
Mirabegron—Fatigue—Betamethasone—ulcerative colitis	0.000122	0.00128	CcSEcCtD
Mirabegron—Tachycardia—Prednisone—ulcerative colitis	0.00012	0.00127	CcSEcCtD
Mirabegron—Skin disorder—Prednisone—ulcerative colitis	0.000119	0.00126	CcSEcCtD
Mirabegron—Asthenia—Hydrocortisone—ulcerative colitis	0.000119	0.00125	CcSEcCtD
Mirabegron—Pruritus—Hydrocortisone—ulcerative colitis	0.000117	0.00123	CcSEcCtD
Mirabegron—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000115	0.00122	CcSEcCtD
Mirabegron—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000115	0.00122	CcSEcCtD
Mirabegron—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000113	0.00119	CcSEcCtD
Mirabegron—Urticaria—Dexamethasone—ulcerative colitis	0.000112	0.00118	CcSEcCtD
Mirabegron—Urticaria—Betamethasone—ulcerative colitis	0.000112	0.00118	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000112	0.00118	CcSEcCtD
Mirabegron—Dizziness—Prednisolone—ulcerative colitis	0.000112	0.00118	CcSEcCtD
Mirabegron—Asthenia—Triamcinolone—ulcerative colitis	0.000112	0.00118	CcSEcCtD
Mirabegron—Abdominal pain—Dexamethasone—ulcerative colitis	0.000112	0.00118	CcSEcCtD
Mirabegron—Abdominal pain—Betamethasone—ulcerative colitis	0.000112	0.00118	CcSEcCtD
Mirabegron—Asthenia—Methylprednisolone—ulcerative colitis	0.000111	0.00117	CcSEcCtD
Mirabegron—Pruritus—Triamcinolone—ulcerative colitis	0.00011	0.00116	CcSEcCtD
Mirabegron—Pruritus—Methylprednisolone—ulcerative colitis	0.00011	0.00116	CcSEcCtD
Mirabegron—Dizziness—Hydrocortisone—ulcerative colitis	0.000109	0.00115	CcSEcCtD
Mirabegron—Dyspepsia—Prednisone—ulcerative colitis	0.000108	0.00114	CcSEcCtD
Mirabegron—Rash—Prednisolone—ulcerative colitis	0.000107	0.00112	CcSEcCtD
Mirabegron—Dermatitis—Prednisolone—ulcerative colitis	0.000107	0.00112	CcSEcCtD
Mirabegron—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000106	0.00112	CcSEcCtD
Mirabegron—Fatigue—Prednisone—ulcerative colitis	0.000106	0.00112	CcSEcCtD
Mirabegron—Headache—Prednisolone—ulcerative colitis	0.000106	0.00112	CcSEcCtD
Mirabegron—Constipation—Prednisone—ulcerative colitis	0.000105	0.00111	CcSEcCtD
Mirabegron—Rash—Hydrocortisone—ulcerative colitis	0.000104	0.0011	CcSEcCtD
Mirabegron—Dermatitis—Hydrocortisone—ulcerative colitis	0.000104	0.0011	CcSEcCtD
Mirabegron—Headache—Hydrocortisone—ulcerative colitis	0.000103	0.00109	CcSEcCtD
Mirabegron—Dizziness—Triamcinolone—ulcerative colitis	0.000103	0.00109	CcSEcCtD
Mirabegron—Dizziness—Methylprednisolone—ulcerative colitis	0.000103	0.00108	CcSEcCtD
Mirabegron—Asthenia—Betamethasone—ulcerative colitis	0.000101	0.00107	CcSEcCtD
Mirabegron—Asthenia—Dexamethasone—ulcerative colitis	0.000101	0.00107	CcSEcCtD
Mirabegron—Gastrointestinal pain—Prednisone—ulcerative colitis	0.0001	0.00106	CcSEcCtD
Mirabegron—Nausea—Prednisolone—ulcerative colitis	0.0001	0.00106	CcSEcCtD
Mirabegron—Pruritus—Betamethasone—ulcerative colitis	9.98e-05	0.00105	CcSEcCtD
Mirabegron—Pruritus—Dexamethasone—ulcerative colitis	9.98e-05	0.00105	CcSEcCtD
Mirabegron—Nausea—Hydrocortisone—ulcerative colitis	9.81e-05	0.00104	CcSEcCtD
Mirabegron—Rash—Triamcinolone—ulcerative colitis	9.81e-05	0.00103	CcSEcCtD
Mirabegron—Dermatitis—Triamcinolone—ulcerative colitis	9.8e-05	0.00103	CcSEcCtD
Mirabegron—Rash—Methylprednisolone—ulcerative colitis	9.78e-05	0.00103	CcSEcCtD
Mirabegron—Dermatitis—Methylprednisolone—ulcerative colitis	9.78e-05	0.00103	CcSEcCtD
Mirabegron—Urticaria—Prednisone—ulcerative colitis	9.76e-05	0.00103	CcSEcCtD
Mirabegron—Headache—Triamcinolone—ulcerative colitis	9.74e-05	0.00103	CcSEcCtD
Mirabegron—Headache—Methylprednisolone—ulcerative colitis	9.72e-05	0.00103	CcSEcCtD
Mirabegron—Abdominal pain—Prednisone—ulcerative colitis	9.71e-05	0.00102	CcSEcCtD
Mirabegron—Diarrhoea—Dexamethasone—ulcerative colitis	9.66e-05	0.00102	CcSEcCtD
Mirabegron—Diarrhoea—Betamethasone—ulcerative colitis	9.66e-05	0.00102	CcSEcCtD
Mirabegron—Dizziness—Betamethasone—ulcerative colitis	9.33e-05	0.000985	CcSEcCtD
Mirabegron—Dizziness—Dexamethasone—ulcerative colitis	9.33e-05	0.000985	CcSEcCtD
Mirabegron—Nausea—Triamcinolone—ulcerative colitis	9.24e-05	0.000975	CcSEcCtD
Mirabegron—Nausea—Methylprednisolone—ulcerative colitis	9.22e-05	0.000972	CcSEcCtD
Mirabegron—Rash—Betamethasone—ulcerative colitis	8.9e-05	0.000939	CcSEcCtD
Mirabegron—Rash—Dexamethasone—ulcerative colitis	8.9e-05	0.000939	CcSEcCtD
Mirabegron—Dermatitis—Dexamethasone—ulcerative colitis	8.89e-05	0.000938	CcSEcCtD
Mirabegron—Dermatitis—Betamethasone—ulcerative colitis	8.89e-05	0.000938	CcSEcCtD
Mirabegron—Headache—Betamethasone—ulcerative colitis	8.84e-05	0.000933	CcSEcCtD
Mirabegron—Headache—Dexamethasone—ulcerative colitis	8.84e-05	0.000933	CcSEcCtD
Mirabegron—Asthenia—Prednisone—ulcerative colitis	8.82e-05	0.00093	CcSEcCtD
Mirabegron—Pruritus—Prednisone—ulcerative colitis	8.69e-05	0.000917	CcSEcCtD
Mirabegron—Diarrhoea—Prednisone—ulcerative colitis	8.41e-05	0.000887	CcSEcCtD
Mirabegron—Nausea—Betamethasone—ulcerative colitis	8.38e-05	0.000884	CcSEcCtD
Mirabegron—Nausea—Dexamethasone—ulcerative colitis	8.38e-05	0.000884	CcSEcCtD
Mirabegron—Dizziness—Prednisone—ulcerative colitis	8.13e-05	0.000857	CcSEcCtD
Mirabegron—Rash—Prednisone—ulcerative colitis	7.75e-05	0.000817	CcSEcCtD
Mirabegron—Dermatitis—Prednisone—ulcerative colitis	7.74e-05	0.000817	CcSEcCtD
Mirabegron—Headache—Prednisone—ulcerative colitis	7.7e-05	0.000812	CcSEcCtD
Mirabegron—Nausea—Prednisone—ulcerative colitis	7.3e-05	0.00077	CcSEcCtD
Mirabegron—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	3.28e-05	0.00869	CbGpPWpGaD
Mirabegron—ADRB3—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	3e-05	0.00794	CbGpPWpGaD
Mirabegron—SLCO1A2—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	2.95e-05	0.00781	CbGpPWpGaD
Mirabegron—ADRB3—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	2.92e-05	0.00773	CbGpPWpGaD
Mirabegron—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	2.88e-05	0.00763	CbGpPWpGaD
Mirabegron—ADRB3—G alpha (s) signalling events—ADCY5—ulcerative colitis	2.87e-05	0.0076	CbGpPWpGaD
Mirabegron—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	2.87e-05	0.00759	CbGpPWpGaD
Mirabegron—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	2.86e-05	0.00757	CbGpPWpGaD
Mirabegron—ALB—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	2.84e-05	0.00751	CbGpPWpGaD
Mirabegron—ADRB3—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	2.82e-05	0.00746	CbGpPWpGaD
Mirabegron—ALB—Folate Metabolism—MPO—ulcerative colitis	2.79e-05	0.00737	CbGpPWpGaD
Mirabegron—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	2.67e-05	0.00706	CbGpPWpGaD
Mirabegron—SLCO1A2—digestive system—ulcerative colitis	2.59e-05	0.0531	CbGeAlD
Mirabegron—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	2.57e-05	0.0068	CbGpPWpGaD
Mirabegron—ABCB1—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	2.52e-05	0.00667	CbGpPWpGaD
Mirabegron—ADRB3—GPCR ligand binding—CXCR1—ulcerative colitis	2.5e-05	0.00662	CbGpPWpGaD
Mirabegron—ADRB3—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	2.48e-05	0.00657	CbGpPWpGaD
Mirabegron—ADRB3—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	2.48e-05	0.00656	CbGpPWpGaD
Mirabegron—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	2.42e-05	0.0064	CbGpPWpGaD
Mirabegron—BCHE—smooth muscle tissue—ulcerative colitis	2.31e-05	0.0473	CbGeAlD
Mirabegron—ALB—Selenium Micronutrient Network—MPO—ulcerative colitis	2.21e-05	0.00586	CbGpPWpGaD
Mirabegron—ADRB3—GPCR ligand binding—CCL20—ulcerative colitis	2.2e-05	0.00581	CbGpPWpGaD
Mirabegron—ORM1—liver—ulcerative colitis	2.19e-05	0.0449	CbGeAlD
Mirabegron—BCHE—Metabolism of proteins—MUC3A—ulcerative colitis	2.15e-05	0.00569	CbGpPWpGaD
Mirabegron—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	2.13e-05	0.00564	CbGpPWpGaD
Mirabegron—ADRB3—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	2.13e-05	0.00563	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	2.05e-05	0.00543	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—PTGS1—ulcerative colitis	2.04e-05	0.00539	CbGpPWpGaD
Mirabegron—ALB—Platelet degranulation—CALM3—ulcerative colitis	1.98e-05	0.00524	CbGpPWpGaD
Mirabegron—ADRB3—GPCR ligand binding—CXCR2—ulcerative colitis	1.96e-05	0.00518	CbGpPWpGaD
Mirabegron—ADRB3—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	1.95e-05	0.00516	CbGpPWpGaD
Mirabegron—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	1.95e-05	0.00515	CbGpPWpGaD
Mirabegron—SLCO1A2—liver—ulcerative colitis	1.93e-05	0.0396	CbGeAlD
Mirabegron—ALB—liver—ulcerative colitis	1.92e-05	0.0393	CbGeAlD
Mirabegron—ALB—Response to elevated platelet cytosolic Ca2+—CALM3—ulcerative colitis	1.89e-05	0.00499	CbGpPWpGaD
Mirabegron—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	1.88e-05	0.00498	CbGpPWpGaD
Mirabegron—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	1.86e-05	0.00492	CbGpPWpGaD
Mirabegron—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	1.85e-05	0.0049	CbGpPWpGaD
Mirabegron—ADRB3—GPCR ligand binding—CCR6—ulcerative colitis	1.84e-05	0.00487	CbGpPWpGaD
Mirabegron—BCHE—digestive system—ulcerative colitis	1.82e-05	0.0373	CbGeAlD
Mirabegron—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	1.81e-05	0.00479	CbGpPWpGaD
Mirabegron—ALB—Vitamin B12 Metabolism—CRP—ulcerative colitis	1.8e-05	0.00476	CbGpPWpGaD
Mirabegron—SLCO1A2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	1.74e-05	0.0046	CbGpPWpGaD
Mirabegron—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	1.74e-05	0.0046	CbGpPWpGaD
Mirabegron—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	1.73e-05	0.00458	CbGpPWpGaD
Mirabegron—BCHE—Transmission across Chemical Synapses—CALM3—ulcerative colitis	1.71e-05	0.00452	CbGpPWpGaD
Mirabegron—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	1.7e-05	0.0045	CbGpPWpGaD
Mirabegron—ALB—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	1.67e-05	0.00442	CbGpPWpGaD
Mirabegron—ALB—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	1.67e-05	0.00442	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PROCR—ulcerative colitis	1.67e-05	0.00441	CbGpPWpGaD
Mirabegron—ALB—Vitamin B12 Metabolism—ICAM1—ulcerative colitis	1.65e-05	0.00438	CbGpPWpGaD
Mirabegron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	1.65e-05	0.00436	CbGpPWpGaD
Mirabegron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	1.64e-05	0.00435	CbGpPWpGaD
Mirabegron—ADRB3—GPCR ligand binding—PTGER4—ulcerative colitis	1.62e-05	0.00429	CbGpPWpGaD
Mirabegron—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	1.61e-05	0.00427	CbGpPWpGaD
Mirabegron—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	1.5e-05	0.00396	CbGpPWpGaD
Mirabegron—ADRB3—GPCR ligand binding—GHRL—ulcerative colitis	1.48e-05	0.00393	CbGpPWpGaD
Mirabegron—ALB—Folate Metabolism—CRP—ulcerative colitis	1.46e-05	0.00388	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	1.44e-05	0.00382	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—CXCR1—ulcerative colitis	1.41e-05	0.00374	CbGpPWpGaD
Mirabegron—CYP2D6—Melatonin metabolism and effects—NFKB1—ulcerative colitis	1.36e-05	0.0036	CbGpPWpGaD
Mirabegron—BCHE—liver—ulcerative colitis	1.36e-05	0.0278	CbGeAlD
Mirabegron—ALB—Folate Metabolism—ICAM1—ulcerative colitis	1.35e-05	0.00356	CbGpPWpGaD
Mirabegron—ABCB1—Allograft Rejection—IL10—ulcerative colitis	1.32e-05	0.0035	CbGpPWpGaD
Mirabegron—BCHE—Neuronal System—CALM3—ulcerative colitis	1.31e-05	0.00346	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—CXCR1—ulcerative colitis	1.28e-05	0.0034	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	1.26e-05	0.00334	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—GNA12—ulcerative colitis	1.26e-05	0.00334	CbGpPWpGaD
Mirabegron—ALB—Vitamin B12 Metabolism—IFNG—ulcerative colitis	1.26e-05	0.00333	CbGpPWpGaD
Mirabegron—ALB—Vitamin B12 Metabolism—RELA—ulcerative colitis	1.24e-05	0.00329	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—CCL20—ulcerative colitis	1.24e-05	0.00328	CbGpPWpGaD
Mirabegron—BCHE—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	1.24e-05	0.00328	CbGpPWpGaD
Mirabegron—ADRB3—GPCR ligand binding—ADRB2—ulcerative colitis	1.23e-05	0.00325	CbGpPWpGaD
Mirabegron—CYP3A4—digestive system—ulcerative colitis	1.23e-05	0.0251	CbGeAlD
Mirabegron—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	1.21e-05	0.0032	CbGpPWpGaD
Mirabegron—CYP2D6—digestive system—ulcerative colitis	1.21e-05	0.0247	CbGeAlD
Mirabegron—ADRB3—GPCR downstream signaling—GNA12—ulcerative colitis	1.17e-05	0.00309	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—CRP—ulcerative colitis	1.16e-05	0.00308	CbGpPWpGaD
Mirabegron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	1.15e-05	0.00303	CbGpPWpGaD
Mirabegron—ABCB1—epithelium—ulcerative colitis	1.14e-05	0.0234	CbGeAlD
Mirabegron—ADRB3—Signaling by GPCR—CCL20—ulcerative colitis	1.13e-05	0.00298	CbGpPWpGaD
Mirabegron—ALB—Vitamin B12 Metabolism—IL1B—ulcerative colitis	1.12e-05	0.00297	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—CXCR2—ulcerative colitis	1.11e-05	0.00293	CbGpPWpGaD
Mirabegron—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	1.08e-05	0.00287	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	1.08e-05	0.00285	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—ICAM1—ulcerative colitis	1.07e-05	0.00283	CbGpPWpGaD
Mirabegron—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	1.06e-05	0.00282	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—GNA12—ulcerative colitis	1.06e-05	0.0028	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—MUC2—ulcerative colitis	1.05e-05	0.00278	CbGpPWpGaD
Mirabegron—ALB—Vitamin B12 Metabolism—NFKB1—ulcerative colitis	1.05e-05	0.00277	CbGpPWpGaD
Mirabegron—ALB—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	1.04e-05	0.00276	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—CCR6—ulcerative colitis	1.04e-05	0.00275	CbGpPWpGaD
Mirabegron—ALB—Folate Metabolism—IFNG—ulcerative colitis	1.02e-05	0.00271	CbGpPWpGaD
Mirabegron—ALB—Folate Metabolism—RELA—ulcerative colitis	1.01e-05	0.00268	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—CXCR2—ulcerative colitis	1e-05	0.00266	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CHP1—ulcerative colitis	9.99e-06	0.00264	CbGpPWpGaD
Mirabegron—CYP2D6—Biological oxidations—PTGS1—ulcerative colitis	9.84e-06	0.0026	CbGpPWpGaD
Mirabegron—BCHE—Neuronal System—ADCY5—ulcerative colitis	9.49e-06	0.00251	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—CCR6—ulcerative colitis	9.44e-06	0.0025	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	9.36e-06	0.00248	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—SEL1L—ulcerative colitis	9.21e-06	0.00244	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—PTGER4—ulcerative colitis	9.16e-06	0.00242	CbGpPWpGaD
Mirabegron—ALB—Folate Metabolism—IL1B—ulcerative colitis	9.14e-06	0.00242	CbGpPWpGaD
Mirabegron—CYP3A4—liver—ulcerative colitis	9.14e-06	0.0187	CbGeAlD
Mirabegron—ALB—Folate Metabolism—IL2—ulcerative colitis	9.1e-06	0.00241	CbGpPWpGaD
Mirabegron—CYP2D6—liver—ulcerative colitis	8.99e-06	0.0184	CbGeAlD
Mirabegron—ABCB1—lymphoid tissue—ulcerative colitis	8.79e-06	0.018	CbGeAlD
Mirabegron—ALB—Platelet activation, signaling and aggregation—CALM3—ulcerative colitis	8.78e-06	0.00232	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CHP1—ulcerative colitis	8.77e-06	0.00232	CbGpPWpGaD
Mirabegron—ABCB1—digestive system—ulcerative colitis	8.68e-06	0.0178	CbGeAlD
Mirabegron—SLCO1A2—Metabolism—DLD—ulcerative colitis	8.62e-06	0.00228	CbGpPWpGaD
Mirabegron—ALB—Folate Metabolism—NFKB1—ulcerative colitis	8.53e-06	0.00226	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	8.5e-06	0.00225	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	8.5e-06	0.00225	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—GHRL—ulcerative colitis	8.38e-06	0.00222	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—PTGER4—ulcerative colitis	8.31e-06	0.0022	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	8.21e-06	0.00217	CbGpPWpGaD
Mirabegron—ALB—Vitamin B12 Metabolism—TNF—ulcerative colitis	8.15e-06	0.00216	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—IFNG—ulcerative colitis	8.14e-06	0.00215	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—RELA—ulcerative colitis	8.03e-06	0.00213	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—PTGS2—ulcerative colitis	7.8e-06	0.00207	CbGpPWpGaD
Mirabegron—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	7.79e-06	0.00206	CbGpPWpGaD
Mirabegron—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	7.77e-06	0.00206	CbGpPWpGaD
Mirabegron—SLCO1A2—SLC-mediated transmembrane transport—ALB—ulcerative colitis	7.67e-06	0.00203	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—GHRL—ulcerative colitis	7.61e-06	0.00201	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CXCR1—ulcerative colitis	7.58e-06	0.00201	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—DLD—ulcerative colitis	7.57e-06	0.002	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	7.44e-06	0.00197	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	7.44e-06	0.00197	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—CALM3—ulcerative colitis	7.37e-06	0.00195	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—IL1B—ulcerative colitis	7.26e-06	0.00192	CbGpPWpGaD
Mirabegron—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	7.23e-06	0.00191	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—ADRB2—ulcerative colitis	6.94e-06	0.00184	CbGpPWpGaD
Mirabegron—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	6.93e-06	0.00184	CbGpPWpGaD
Mirabegron—ABCB1—Allograft Rejection—IL2—ulcerative colitis	6.91e-06	0.00183	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—NFKB1—ulcerative colitis	6.77e-06	0.00179	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CCL20—ulcerative colitis	6.66e-06	0.00176	CbGpPWpGaD
Mirabegron—ALB—Folate Metabolism—TNF—ulcerative colitis	6.63e-06	0.00175	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—GHRL—ulcerative colitis	6.6e-06	0.00175	CbGpPWpGaD
Mirabegron—ALB—Vitamin B12 Metabolism—IL6—ulcerative colitis	6.58e-06	0.00174	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—GNA12—ulcerative colitis	6.5e-06	0.00172	CbGpPWpGaD
Mirabegron—ABCB1—liver—ulcerative colitis	6.47e-06	0.0133	CbGeAlD
Mirabegron—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	6.43e-06	0.0017	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—ITGAL—ulcerative colitis	6.38e-06	0.00169	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—ADRB2—ulcerative colitis	6.3e-06	0.00167	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—GNA12—ulcerative colitis	6.26e-06	0.00166	CbGpPWpGaD
Mirabegron—SLCO1A2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	6.23e-06	0.00165	CbGpPWpGaD
Mirabegron—ALB—Platelet degranulation—TGFB1—ulcerative colitis	6.09e-06	0.00161	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CXCR2—ulcerative colitis	5.93e-06	0.00157	CbGpPWpGaD
Mirabegron—ADRB3—GPCR ligand binding—CXCL8—ulcerative colitis	5.93e-06	0.00157	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—ADCY5—ulcerative colitis	5.89e-06	0.00156	CbGpPWpGaD
Mirabegron—ALB—Folate Metabolism—TP53—ulcerative colitis	5.85e-06	0.00155	CbGpPWpGaD
Mirabegron—SLCO1A2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	5.82e-06	0.00154	CbGpPWpGaD
Mirabegron—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ulcerative colitis	5.8e-06	0.00154	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CCR6—ulcerative colitis	5.58e-06	0.00148	CbGpPWpGaD
Mirabegron—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	5.39e-06	0.00143	CbGpPWpGaD
Mirabegron—ALB—Folate Metabolism—IL6—ulcerative colitis	5.35e-06	0.00142	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—ADCY5—ulcerative colitis	5.35e-06	0.00142	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	5.29e-06	0.0014	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MAML2—ulcerative colitis	5.29e-06	0.0014	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—TNF—ulcerative colitis	5.27e-06	0.00139	CbGpPWpGaD
Mirabegron—ABCB1—Allograft Rejection—TNF—ulcerative colitis	5.03e-06	0.00133	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PTGER4—ulcerative colitis	4.91e-06	0.0013	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CHP1—ulcerative colitis	4.88e-06	0.00129	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	4.64e-06	0.00123	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	4.57e-06	0.00121	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.56e-06	0.00121	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—CALM3—ulcerative colitis	4.52e-06	0.0012	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—GHRL—ulcerative colitis	4.5e-06	0.00119	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CALM3—ulcerative colitis	4.36e-06	0.00115	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—RIPK2—ulcerative colitis	4.29e-06	0.00114	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CHP1—ulcerative colitis	4.28e-06	0.00113	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—IL6—ulcerative colitis	4.25e-06	0.00113	CbGpPWpGaD
Mirabegron—ALB—Metabolism—DLD—ulcerative colitis	4.21e-06	0.00112	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PTGS1—ulcerative colitis	4.17e-06	0.0011	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—MMP1—ulcerative colitis	4.1e-06	0.00109	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.1e-06	0.00109	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CHP1—ulcerative colitis	4.03e-06	0.00107	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4e-06	0.00106	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	3.97e-06	0.00105	CbGpPWpGaD
Mirabegron—SLCO1A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	3.9e-06	0.00103	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CALM3—ulcerative colitis	3.75e-06	0.000994	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ADRB2—ulcerative colitis	3.72e-06	0.000985	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—DLD—ulcerative colitis	3.69e-06	0.000977	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	3.68e-06	0.000973	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—JAK2—ulcerative colitis	3.67e-06	0.000972	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PTGS1—ulcerative colitis	3.66e-06	0.000968	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.6e-06	0.000952	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.59e-06	0.000949	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—DLD—ulcerative colitis	3.48e-06	0.000921	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	3.46e-06	0.000916	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—CXCL8—ulcerative colitis	3.35e-06	0.000887	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—JAK2—ulcerative colitis	3.33e-06	0.000882	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CALM3—ulcerative colitis	3.29e-06	0.000872	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—IL2—ulcerative colitis	3.2e-06	0.000848	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	3.19e-06	0.000845	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ADCY5—ulcerative colitis	3.16e-06	0.000836	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.15e-06	0.000833	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	3.05e-06	0.000806	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—CXCL8—ulcerative colitis	3.04e-06	0.000805	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ABCB1—ulcerative colitis	2.92e-06	0.000773	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—IL2—ulcerative colitis	2.91e-06	0.00077	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—MMP1—ulcerative colitis	2.9e-06	0.000769	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.84e-06	0.000752	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ADCY5—ulcerative colitis	2.72e-06	0.000721	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	2.7e-06	0.000715	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	2.66e-06	0.000704	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—CXCL8—ulcerative colitis	2.64e-06	0.000698	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CHP1—ulcerative colitis	2.64e-06	0.000697	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ABCB1—ulcerative colitis	2.56e-06	0.000678	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.49e-06	0.000659	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	2.48e-06	0.000657	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ADCY5—ulcerative colitis	2.39e-06	0.000632	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—DLD—ulcerative colitis	2.27e-06	0.000602	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.23e-06	0.00059	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	2.19e-06	0.000579	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—JAK2—ulcerative colitis	2.05e-06	0.000541	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PTGS1—ulcerative colitis	2.04e-06	0.000539	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PPARG—ulcerative colitis	2.03e-06	0.000538	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—JAK2—ulcerative colitis	1.97e-06	0.000521	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—RELA—ulcerative colitis	1.91e-06	0.000505	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CALM3—ulcerative colitis	1.83e-06	0.000485	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ALB—ulcerative colitis	1.83e-06	0.000483	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CXCL8—ulcerative colitis	1.8e-06	0.000476	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.79e-06	0.000472	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—IL2—ulcerative colitis	1.78e-06	0.000472	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PPARG—ulcerative colitis	1.78e-06	0.000472	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.75e-06	0.000464	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL2—ulcerative colitis	1.72e-06	0.000455	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—IL6—ulcerative colitis	1.71e-06	0.000452	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PTGS1—ulcerative colitis	1.68e-06	0.000445	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.67e-06	0.000442	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MMP9—ulcerative colitis	1.63e-06	0.00043	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NFKB1—ulcerative colitis	1.61e-06	0.000426	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CALM3—ulcerative colitis	1.61e-06	0.000425	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ALB—ulcerative colitis	1.6e-06	0.000424	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PTGS2—ulcerative colitis	1.6e-06	0.000423	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CALM3—ulcerative colitis	1.51e-06	0.000401	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—STAT3—ulcerative colitis	1.45e-06	0.000383	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ABCB1—ulcerative colitis	1.43e-06	0.000378	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PTGS2—ulcerative colitis	1.4e-06	0.000371	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—TGFB1—ulcerative colitis	1.39e-06	0.000368	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TGFB1—ulcerative colitis	1.34e-06	0.000355	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ADCY5—ulcerative colitis	1.33e-06	0.000352	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ABCB1—ulcerative colitis	1.18e-06	0.000312	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ADCY5—ulcerative colitis	1.17e-06	0.000309	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—TP53—ulcerative colitis	1.15e-06	0.000303	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TP53—ulcerative colitis	1.1e-06	0.000292	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.1e-06	0.000291	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ADCY5—ulcerative colitis	1.1e-06	0.000291	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL6—ulcerative colitis	1.01e-06	0.000267	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPARG—ulcerative colitis	9.92e-07	0.000263	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CALM3—ulcerative colitis	9.9e-07	0.000262	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPARG—ulcerative colitis	8.7e-07	0.00023	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPARG—ulcerative colitis	8.19e-07	0.000217	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALB—ulcerative colitis	7.82e-07	0.000207	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PTGS2—ulcerative colitis	7.81e-07	0.000207	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ABCB1—ulcerative colitis	7.7e-07	0.000204	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALB—ulcerative colitis	7.37e-07	0.000195	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ADCY5—ulcerative colitis	7.18e-07	0.00019	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PTGS2—ulcerative colitis	6.84e-07	0.000181	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PTGS2—ulcerative colitis	6.45e-07	0.000171	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPARG—ulcerative colitis	5.36e-07	0.000142	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALB—ulcerative colitis	4.82e-07	0.000127	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PTGS2—ulcerative colitis	4.21e-07	0.000112	CbGpPWpGaD
